欢迎访问上海芮晖化工科技有限公司官方网站！
咨询电话: 021-31433387|邮箱: sales@rechemscience.com
产品分类
联系我们
| 电话： | 021-31433387 |
| 15618786686(微信) | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | rechem@outlook.com |
首页 > 产品展示
| 目录号 | 产品名称 | 产品描述 |
| R2033242 | Adalimumab | Adalimumab 是一种人源的单克隆 IgG1 抗体，靶向肿瘤坏死因子α (TNF-α)。 |
| R2033243 | Infliximab | Infliximab is a humanized antibody against tumor necrosis factor α (TNF-α) that |
| R2033244 | Rituximab | Rituximab是用于治疗某些自身免疫疾病和癌症类型的抗CD20嵌合单克隆抗体。 |
| R2033245 | Ipilimumab;MDX-010;BMS-734016 | Ipilimumab 是一种全人类单克隆抗体 IgG1κ，能够抗 CTLA-4（一种由活化的 T 细胞产生的免疫抑制分子）。 |
| R2033246 | Vedolizumab | Vedolizumab是一种靶向α4β7整联蛋白 (integrin) 的人源化单克隆抗体，用来治疗溃疡性结肠炎和克罗恩病。 |
| R2033247 | Denosumab | Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast |
| R2033248 | Evolocumab | Evolocumab is a human IgG2 monoclonal antibody that binds to human PCSK9 (Propro |
| R2033249 | Alirocumab | Alirocumab is a human monoclonal antibody that inhibits PCSK9. It is produced by |
| R2033250 | Eculizumab | Eculizumab is a recombinant humanized monoclonal antibody against the complement |
| R2033251 | Ustekinumab | Ustekinumab 是一种抗 IL-12/IL-23 的人源单克隆 IgG1κ 抗体。 |
| R2033252 | Omalizumab | Omalizumab is a recombinant, humanized, monoclonal antibody against human immuno |
| R2033253 | Ramucirumab | Ramucirumab 是人 VEGFR-2 拮抗剂，可用于治疗实体瘤。Ramucirumab 是一种人源化单克隆抗体，可与 VEGFR-2 结合，阻止 VEG |
| R2033254 | Secukinumab | Secukinumab是一种重组、高亲和性、全人免疫球蛋白G1κ单克隆抗体,选择性地与IL-17A结合从而中和IL-17A的作用,目前处于III期临床试验。 |
| R2033255 | Daratumumab | Daratumumab is a human monoclonal antibody that targets CD38, a cell surface pro |
| R2033256 | Atezolizumab | Atezolizumab 是一种人源化单克隆抗体 IgG1，抵抗程序性死亡因子配体1 (PD-L1)，用于癌症研究。 |
| R2033257 | Dulaglutide (LY2189265) | Dulaglutide (LY2189265) 是胰高血糖素样肽-1 (GLP-1) 受体激动剂。 |
| R2033258 | Tocilizumab | Tocilizumab (anti-IL-6R) is a humanized monoclonal antibody that binds to the in |
| R2033259 | Natalizumab | Natalizumab 是一种重组的人源化单克隆抗体，与 α4β1-整联蛋白 (α4β1-integrin) 结合并阻断其与血管细胞粘附分子 1 (VCAM-1 |
| R2033260 | Pertuzumab | Pertuzumab 是一种人源化单克隆抗体，是一种HER2二聚抑制剂。可用于治疗转移性HER2 阳性乳腺癌。 |
| R2033261 | Panitumumab | Tocilizumab (anti-IL-6R) is a humanized monoclonal antibody that binds to the in |
| R2033262 | Mepolizumab | Mepolizumab is a humanized IL-5 antagonist monoclonal antibody produced by recom |
| R2033263 | Alemtuzumab | Alemtuzumab is a humanized monoclonal antibody against CD52, an antigen found on |
| R2033264 | Efmoroctocog alfa | Efmoroctocog alfa is a fully recombinant factor VIII-Fc fusion protein (rFVIIIFc |
| R2053266 | ULK-101;ULK101 | ULK-101 是一个有效的、选择性的ULK1 抑制剂，其在体外测得的对ULK1和 ULK2的IC50 值分别为 1.6 nM和30 nM。 |
| R2053267 | EIDD-2801;EIDD2801 | EIDD-2801 是核糖核苷类似物 EIDD-1931 的口服生物可利用的异丙酯前药。EIDD-2801 显示出广泛的抗流感病毒 (influenza vir |
